National Center FOR Hiv/aids

The National Center for HIV/AIDS, Dermatology and STDs (NCHADS) is a Cambodian government agency operating under the Ministry of Health. Established to manage the treatment and prevention of HIV/AIDS and sexually transmitted diseases, NCHADS plays a pivotal role in Cambodia's public health infrastructure. Its main offices are located in Phnom Penh, the capital city. (nchads.gov.kh)

NCHADS is responsible for developing and disseminating policies, strategies, and guidelines for the implementation of the Continuum of Care in Cambodia. This includes planning, coordinating, and supervising the scaling-up and expansion of HIV/AIDS and STD services. Additionally, NCHADS assists in identifying the needs for drugs and equipment for the Continuum of Care and monitors and evaluates the different components to improve the quality of care and services.

As a government agency, NCHADS operates a centralized distribution network for pharmaceuticals and medical supplies related to HIV/AIDS and STDs. While specific details about warehouse locations and logistics capabilities are not publicly disclosed, NCHADS collaborates with various health departments and organizations to ensure the effective distribution of medical supplies across Cambodia. This collaboration includes working with Provincial Health Departments and other local NGOs to support people living with HIV.

NCHADS functions as a central authority in Cambodia's pharmaceutical supply chain, primarily focusing on the procurement, distribution, and management of HIV/AIDS and STD-related medical products. While it does not operate as a traditional wholesaler or distributor, NCHADS coordinates with various stakeholders, including the Ministry of Health, Provincial Health Departments, and non-governmental organizations, to ensure the availability and distribution of essential medical supplies.

NCHADS's sourcing strategy reveals a high concentration in its pharmaceutical imports, with a total import value of $450,000 USD from India across nine shipments. The top two products imported are Amphotericin ($300,000 USD) and Atazanavir ($150,000 USD), accounting for 66.7% and 33.3% of the total import value, respectively. This concentration indicates a strategic focus on specific therapeutic areas critical to HIV/AIDS treatment.

The shipment data suggests a stable relationship with Indian suppliers, as evidenced by the consistent import volumes over the period. The primary suppliers include Mylan Laboratories Limited, Emcure Pharmaceuticals Limited, and Poornima Healthcare, which collectively account for 97.8% of the total import value. This indicates a reliance on a select group of suppliers for essential HIV/AIDS medications.

NCHADS's supply chain resilience is supported by its partnerships with reputable Indian pharmaceutical manufacturers, such as Mylan Laboratories Limited, Emcure Pharmaceuticals Limited, and Poornima Healthcare. These suppliers are known for their adherence to Good Manufacturing Practices (GMP) and international quality standards, ensuring the reliability and safety of the imported medications. However, the concentration of imports from a limited number of suppliers may pose risks in the event of supply disruptions. Diversifying the supplier base and establishing backup suppliers could enhance the resilience of NCHADS's supply chain.

The concentrated sourcing pattern of NCHADS positions it as a significant purchaser of specific HIV/AIDS medications from India, potentially offering leverage in negotiations with suppliers. For Indian exporters, this presents an opportunity to strengthen relationships with NCHADS by ensuring consistent supply and quality, thereby securing a stable market for their products. Additionally, understanding NCHADS's procurement needs and aligning product offerings accordingly can enhance the competitiveness of Indian exporters in the Cambodian market.

The Ministry of Health (MoH) is the primary regulatory authority overseeing pharmaceutical imports in Cambodia. The Law on the Management of Pharmaceuticals governs the importation, distribution, and sale of pharmaceutical products, including requirements for import licenses and product registration. According to this law, authorization from the MoH is required for the importation of pharmaceuticals, and all imported pharmaceutical products must be registered with the MoH before distribution. (wipo.int)

Import licensing for pharmaceuticals in Cambodia is managed by the MoH. All imported medicines and medical products must be registered with the MoH, which involves submitting an application form, GMP or ISO certificates, a free sale certificate, a letter of authorization, and the product’s manual. The registration process typically takes three to six months, depending on documentation and MoH workload.

Imported pharmaceutical products must undergo laboratory testing by the MoH to ensure quality and safety. All imported pharmaceutical products are required to have at least 18 months validity before the expiry date. Medical devices are classified into four categories according to their levels of risk: low, fairly low, fairly high, and high. Companies can register their imported products online via the MoH registration platform known as the Cambodia Pharmaceutical Online Registration System (CamPORS).

Between 2024 and 2026, Cambodia has implemented several policy changes affecting pharmaceutical imports. These include the introduction of the Cambodia Pharmaceutical Online Registration System (CamPORS) to streamline the registration process for imported pharmaceutical products. Additionally, the MoH has emphasized the need for GMP or ISO certificates from exporting companies to ensure product quality. These changes aim to enhance the efficiency and safety of pharmaceutical imports into Cambodia.

NCHADS's focus on importing Amphotericin and Atazanavir aligns with its mission to provide comprehensive care for individuals living with HIV/AIDS. Amphotericin is essential for treating fungal infections, which are common among immunocompromised patients, while Atazanavir is a critical component of antiretroviral therapy. The demand for these products is driven by the need to manage opportunistic infections and maintain viral suppression in HIV-positive individuals.

NCHADS's sourcing strategy emphasizes the procurement of generic antiretroviral medications, primarily from India, known for its robust pharmaceutical manufacturing sector. The focus on specific formulations, such as Amphotericin and Atazanavir, indicates a targeted approach to meet the therapeutic needs of the HIV/AIDS population in Cambodia. This strategy ensures access to essential medications while managing costs effectively.

By importing and distributing essential HIV/AIDS medications, NCHADS serves the public health sector in Cambodia, including government hospitals, clinics, and health programs. Its role is crucial in ensuring the availability of life-saving treatments for individuals living with HIV/AIDS, thereby positioning it as a key player in the Cambodian healthcare system.

There is a realistic opportunity for new Indian suppliers to engage with NCHADS by offering high-quality, cost-effective generic antiretroviral medications. To identify gaps in NCHADS's current sourcing, potential suppliers should analyze the therapeutic areas and formulations currently imported and assess the demand for additional products. Building relationships with NCHADS and understanding its procurement processes can facilitate entry into the Cambodian market.

Indian exporters seeking to supply NCHADS must ensure their products are registered with the Cambodian MoH, which involves providing GMP or ISO certificates, a free sale certificate, a letter of authorization, and the product’s manual. Additionally, products must have at least 18 months validity before the expiry date. Compliance with these requirements is essential for successful market entry.

To establish a relationship with NCHADS, Indian exporters should initiate contact through formal channels, such as the MoH's registration platform (CamPORS), to understand the registration process and requirements. Participating in tenders and responding to calls for proposals can also be effective strategies. Understanding the regulatory framework and ensuring compliance with all requirements will facilitate a smoother entry into the Cambodian market.